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Targeted Estimation of Variable Importance
Measures with Interval-Censored Outcomes
Stephanie Sapp, Mark J. van der Laan, and Kimberly Page
Abstract
In most experimental and observational studies, participants are not followed in
continuous time. Instead, data is collected about participants only at certain mon-
itoring times. These monitoring times are random, and often participant specific.
As a result, outcomes are only known up to random time intervals, resulting in
interval-censored data. In contrast, when estimating variable importance mea-
sures on interval-censored outcomes, practitioners often ignore the presence of
interval-censoring, and instead treat the data as continuous or right-censored, ap-
plying ad-hoc approaches to mask the true interval-censoring. In this paper, we de-
scribe Targeted Minimum Loss-based Estimation methods tailored for estimation
of variable importance measures with interval-censored outcomes. We demon-
strate the performance of the interval-censored TMLE procedure through simula-
tion studies, and apply the method to analyze the effects of a variety of variables
on spontaneous hepatitis C virus clearance among injection drug users, using data
from the “International Collaboration of Incident HIV and HCV in Injecting Co-
horts” project.
1 Introduction
Determining the effect importance of a large collection of biomarkers on an out-
come is a frequent goal in applications involving epidemiology. For example, epi-
demiologists often wish to determine the effects of a variety of behavioral and bi-
ological factors on health outcomes. In practice, epidemiological data is not col-
lected in continuous time, and is rather only measured at random monitoring times,
resulting in interval-censored outcomes.
Practitioners often ignore interval-censoring when conducting their analy-
sis. One common approach involves using a misspecified parametric model and
forward imputing the outcome to the final time of interest. For example, in analyz-
ing factors associated with the interval-censored outcome of spontaneous hepatitis
C virus clearance within 2 years of incident infection, Grebely et al. (2012a) used
a logistic regression approach. Their analysis both assumed a logistic relationship
between variables and outcome, and ignored interval-censoring of clearance by for-
ward imputing the clearance outcome to the 2 year endpoint.
Another approach ignoring interval censoring involves obtaining estimates
using targeted learning methodology, but forward imputing the outcome to the final
time of interest. This approach is more principled in the sense that the estimates
obtained would be valid in the absence of interval-censoring, but nonetheless fails
to account for interval-censoring. For example, Bembom et al. (2009) estimated the
effects of a variety of biomarkers on viral load outcome under HIV treatment change
using Targeted Minimum Loss-based Estimation of variable importance measures,
but ignored interval-censoring of the viral load outcome, and instead effectively
used forward imputation.
To account for interval-censoring, nonparametric maximum likelihood es-
timators (NPMLE) for the marginal distribution of an interval-censored event time
have been studied for various types of interval-censored data. For example, Groene-
boom and Wellner (1992) study the NPMLE for “case 1” data, and Geskus and
Groeneboom (1999) study the NPMLE for “case 2” data. “Case 1”, or current sta-
tus, data is obtained when participants are only observed once, at a fixed monitoring
time. At this monitoring time, we observe an indicator of whether or not the event
has occurred. “Case 2” data involves monitoring participants twice, and at each
monitoring time, observing an indicator of whether or not the event has occurred.
However, these NPMLE approaches only estimate the marginal event time distribu-
tion, and thus do not provide estimates of covariate effects on the outcome event.
Semiparametric regression models for interval-censored data have been pro-
posed to analyze the effects of various covariates on the outcome event. Propor-
tional hazards models have been studied by, for example, Cai and Betensky (2003),
Huang and Wellner (1997), and Finkelstein (1986). Proportional odds models have
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been studied by, for example, Rabinowitz, Betensky, and Tsiatis (2000), Rossini
and Tsiatis (1996), and Huang and Wellner (1997). Accelerated failure time mod-
els have been studied by, for example, Tian and Cai (2006), Huang and Wellner
(1997), and Rabinowitz, Tsiatis, and Aragon (1995). In these models, effect esti-
mates are given by the estimated regression coefficient, and hence still suffer from
model misspecification.
In this paper, we propose making less restrictive modeling assumptions and
clearly defining the target parameter of interest when analyzing the effects of a va-
riety of variables on an interval-censored outcome. In particular, we define variable
importance measures (VIM) as functions of the true data generating distribution,
instead of as coefficients in possibly misspecified models. We use a nonparametric
statistical model, which makes no statistical assumptions about the form of the un-
derlying true data generating distribution, and only make non-testable assumptions
about the causal model generating the data.
We develop Targeted Minimum Loss-based Estimation (TMLE) methods to
estimate VIM in the presence of interval-censored outcomes. Our interval-censored
TMLE procedure (IC-TMLE) provides consistent estimates, valid inference, and
a variety of other desirable properties under regularity conditions. We show that
ignoring interval-censoring leads to incorrect VIM estimates and inference, and
demonstrate the superior performance of IC-TMLE. We apply IC-TMLE to esti-
mate VIM of spontaneous hepatitis C virus (HCV) clearance among injection drug
users, using data from the “International Collaboration of Incident HIV and HCV
in Injecting Cohorts” (InC3) project.
The remainder of our paper is organized as follows. We formalize the ob-
served data structure in Section 2. The target VIM parameter, including two formu-
lation possibilities, are presented in Section 3. We discuss estimation of VIM and
the IC-TMLE algorithm in Section 4. Simulation study results appear in Section 5.
We use IC-TMLE to analyze data from the InC3 project in Section 6. Finally, we
conclude in Section 7.
2 Data Structure
2.1 Observed Data
We consider the following observed data structure. Observations, consisting of
time-varying covariates L(t) and time-to-event outcome process Y (t), are collected
from each participant i = 1, . . . ,n at different discrete monitoring times t. The out-
come process Y (t) indicates whether the event has been observed by time t. Moni-
toring process ∆(t) indicates whether monitoring occurs at time t. Each participant
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is observed at time t = 0: we measure baseline covariates W = L(0), and assign or
observe binary “treatment” A for which we want to estimate a VIM. Note that the
definitions of A and W depend upon the VIM being analyzed. Since our outcome
of interest is a time-to-event, we assume the event has not yet occurred at baseline,
and the outcome process Y (t) only jumps once.
Although, for simplicity, this paper only discusses the case of a single treat-
ment at time 0, the approach described in this paper can be easily extended to treat-
ments at multiple time points. Note that A does not need to be an actual treat-
ment: it may be a behavioral or biological marker observed at baseline. We label
subsequent monitoring times as t = 1,2, . . . ,τ , where τ is the monitoring time at
which we aim to measure the final outcome. Note that the t numerical labels can
be determined by bucketing the true monitoring times into τ intervals, or by sim-
ply numbering the visits. Since not every participant is observed at every moni-
toring time, we encode the measurements at every monitoring time t as the tuple(
∆(t), ∆(t)L(t), ∆(t)Y (t)
)
=
(
∆(t), L∗(t), Y ∗(t)
)
, so that the covariates and out-
come process are defined at every t. If we do observe data at time t, the true L(t)
and Y (t) values are used, since ∆(t) = 1. Otherwise, monitoring does not occur at
time t, so ∆(t) = 0, and we use degenerate values for L(t) and Y (t). This observed
data structure can be represented, ordered in the assumed collection order, as the
random variable O =
(
W, A,
{
∆(t), L∗(t), Y ∗(t)
}τ
t=1
)
.
Since our interest is in observing the value of Y (τ), the missing indica-
tor of primary interest is ∆(τ). We view the intermediate ∆(t) indicators and
associated measurements as simply intermediate data, rather than missing indi-
cators to intervene upon. To clarify this distinction, we use the notation L′ ={
∆(t), L∗(t), Y ∗(t)
}τ−1
t=1
as a single variable indicating all intermediate data, Y =
Y ∗(τ) as the final outcome of interest, and ∆ = ∆(τ) as the indicator of monitoring
at that final time. Using this notation, we represent the observed data structure as
O =
(
W, A, L′, ∆, Y
)
.
2.2 Statistical and Causal Model
We assume the following non-parametric structural causal model (NPSCM), as in
Pearl (2000), which encodes the non-testable causal assumptions about the time-
ordering of the observed data.
W = fW (UW )
A = fA(W,UA)
L′ = fL′(W,A,UL′)
∆ = f∆(W,A,L
′,U∆)
Y = fY (W,A,L
′,∆,UY )


(1)
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In equations (1),U = (UW ,UA,UL′,U∆,UY ) are unobserved exogenous random vari-
ables, while the functions f are deterministic and not restricted to any functional
form. Each endogenous variableW,A,L′,∆,Y is only a function of its parents (vari-
ables preceding it in the assumed time ordering), and its corresponding U random
variable, which captures additional randomness in each endogenous variable not
accounted for by the parents alone.
Our statistical model is indexed by the functions f and the random variable
U . We put no restrictions on their statistical distributions. We will make random-
ization assumptions in the next section, which are non-testable causal assumptions.
However, our statistical model remains semiparametric because we make no distri-
butional form assumptions. Hence, the observed data O is a random variable with
data generating distribution P, which is an element of semiparametric statistical
model M , i.e., O ∼ P ∈M .
3 Target Parameter
3.1 Formulation Possibilities
We focus on the risk difference parameter, and consider two possible formulations
of this target parameter.
3.1.1 Static Intervention Formulation
The first possible target parameter formulation is given by:
ψFstatic = E
[
Y A=1,∆=1−Y A=0,∆=1
]
= E
[
Y 1,1
]
−E
[
Y 0,1
]
(2)
The following static intervention on the NPSCM yields the counterfactual outcome
Y a,1:
d(a,1) :
{
A = a
∆ = 1
(3)
The above intervention is straightforward to understand: we set the treatment at
baseline to the desired value, and ensure that monitoring occurs at the final time τ ,
so that we can check whether the event of interest has occurred. Using the NPSCM,
counterfactual data following the intervention (3) can be generated as follows. First,
drawU . Then, generateW = fW (UW ). Next, generate L
′,a = fL′(W,a,UL′). Finally,
generate Y a,1 = fY (W,a,L
′,1).
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3.1.2 Stochastic Intervention Formulation
To reflect the fact that our parameter of interest is whether the event of interest has
occurred by time τ , and hence does not necessarily depend on being monitored at
exactly time τ , we introduce the following redefinition of the data. At time t = 0,
define Y #(0) = Y ∗(0), ∆#(0) = ∆(0), and L#(0) = L∗(0). At times t > 0:
Y #(t) = Y #(t−1) if I(Y #(t−1) = 1)
∆#(t) = ∆#(t−1) if I(Y #(t−1) = 1)
L#(t) = L#(t−1) if I(Y #(t−1) = 1)
(4)
The above redefinition sets all values of the data deterministically after observing
that the event of interest has occurred. Note that Y #(t) = 1 implies that ∆#(t) = 1.
Also, note that Y #(t) and ∆#(t) will equal Y ∗(t) and ∆(t), unless ∆(t) = 0 and
Y ∗(t) = 0, respectively. This is due to the fact that the data redefinition only changes
the values of Y ∗(t) and ∆(t) if they are not already equal to one. Using these obser-
vations, we can express the data redefinition (4) equivalently as:
Y #(t) = Y ∗(t)+
(
1−Y ∗(t)
)
Y #(t−1)
∆#(t) = ∆(t)+
(
1−∆(t)
)
∆#(t−1) Y #(t−1)
L#(t) = L#(t−1) Y #(t−1)+L∗(t)
(
1−Y #(t−1)
) (5)
Using redefinition (5), our observed data structure is now O# =
(
W,A,L
′#,∆#,Y #
)
,
where ∆# = ∆#(τ) and Y # = Y #(τ).
With this redefinition in hand, we now define a second possible target pa-
rameter:
ψFstochastic = E
[
Y #,A=1,∆=δ −Y #,A=0,∆=δ
]
= E
[
Y #,1,δ
]
−E
[
Y #,0,δ
]
(6)
The following stochastic intervention on the NPSCM (involving a static in-
tervention on baseline treatment A, and stochastic intervention on the monitoring
mechanism ∆#) yields the counterfactual outcome Y #,a,δ :
d(a,δ ) :


A = a
∆# = δ =
{
1 if Y #(τ −1) = 0
∆#(τ −1) if Y #(τ −1) = 1
(7)
The stochastic intervention on the monitoring process ∆# ensures that we
enforce monitoring at time τ if we have not yet observed the event of interest, and
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do not intervene on the monitoring process if the event of interest has already been
observed (in that case, ∆# = ∆#(τ −1) already, by the redefinition of the data).
As in the static intervention case, we can use the NPSCM to generate coun-
terfactual data following the intervention (7). We begin by drawing U . Then, we
generate W = fW (UW ). Next, we generate L
′ = fL′(W,a,UL′). Finally, we compute
the value δ from L′, and generate Y = fY (W,a,L
′,δ ).
3.1.3 Equivalence of Proposed Intervention Formulations
While the stochastic intervention formulation might seem more desirable, since it
does not require intervention when the event of interest is already known to have
occurred, both formulations result in the same statistical parameter. For a proof, see
Appendix C. In the remainder of this paper, we use the simpler static intervention
representation of the parameter. Hence, we our target VIM parameter is:
ψ = EW
[
EL′
[
E
[
Y |W,A = 1,L′,∆ = 1
]]]
−EW
[
EL′
[
E
[
Y |W,A = 0,L′,∆ = 1
]]]
= ψ1−ψ0
(8)
In principle, the two formulations possibilities would require two sets of
identifiability assumptions, as discussed in Appendix A and Appendix B. However,
we show in Appendix C that the identifiability assumptions are equivalent.
The causal assumptions needed for (8) to be identifiable from the distribu-
tion of the observed data are: consistency, randomization, and positivity. The con-
sistency assumption requires that intervening on treatment to set A= a and interven-
ing on monitoring to set ∆ = 1 in the NPSCM yields the observed outcome Y if the
observed treatment and monitoring values equal a and 1, respectively. The random-
ization assumption requires that, given the observed past, treatment and monitoring
are independent of counterfactual outcomes. The positivity assumption requires
that, given the observed past, the conditional probability of treatment A = a, and
monitoring ∆ = 1, are positive.
Note that even in the case that the causal assumptions fail to hold, the pa-
rameter (8) still remains an interesting variable importance measure of the effect of
A on the outcome Y . In that case, (8) represents the effect of A on Y , controlling for
the measured confounders W , and ensuring that monitoring occurs at the final time
of interest.
3.2 Representation as Function of Iterated Conditional Means
Observe that the VIM ψ is a function of the density P(O), since, if P(O) were
known, we could calculate (8) exactly: first compute conditional distributions from
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the full joint distribution, then perform integrations.
Although ψ depends on P, we do not need to know all of P in order to
calculate ψ . This can be seen by factorizing P(O) as follows:
P(O) = PW (W ) PA(A|W ) PL′(L
′|A,W ) P∆(∆|W,A,L
′) PY (Y |W,A,L
′
,∆)
= QW gA QL′ g∆ QY (9)
Now, observe that our VIM parameter (8) only depends on the distribution P through
its Q factors in (9), and hence may be represented as ψ(Q). Furthermore, observe
that ψ(Q) may be represented as an iterative conditional expectation: first con-
ditioning on {L′,W}, then on only {W}. This can be seen as follows. We first
introduce some additional notation:
Q¯
a,1
Y = E
[
Y |W,A = a,L′,∆ = 1
]
Q¯
a,1
L′
= EL′
[
Q¯
a,1
Y |W,A = a
]
Q¯
a,1
W = EW
[
Q¯
a,1
L′
]


(10)
Using the conditional mean notation (10), we can re-express the components of our
target parameter as follows:
ψa = EW
[
EL′
[
E
[
Y |W,A = a,L′,∆ = 1
]]]
= EW
[
EL′
[
Q¯
a,1
Y
]]
= EW
[
Q¯
a,1
L′
]
= Q¯a,1W (11)
4 Estimation
4.1 TargetedMinimumLoss-based Estimation (TMLE)Overview
Targeted Minimum Loss-based Estimation (TMLE) is a general framework for con-
structing estimators of a statistical parameter ψ under a semiparametric model. The
procedure consists of two steps. The first step involves obtaining an initial estimate
Qˆ of the portion Q of the data-generating distribution P that is needed to calculate
ψ . The second step obtains an update Qˆ∗ of Qˆ through a fluctuation that is targeted
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toward optimizing the bias-variance trade-off for ψ . Finally, the TMLE estimate of
ψ is given by the substitution (plug-in) estimate ψˆ = ψ(Qˆ∗).
We recommend using Super Learning to obtain the initial estimate of Q.
Super Learning is a machine learning algorithm which involves proposing a library
of candidates estimators, and using cross-validation to data-adaptively select the
weighted combination of the candidates that minimizes the cross-validated risk.
Through this process, Super Learning does not make any parametric assumptions
about the form of density estimated. We refer to van der Laan, Polley, and Hubbard
(2007) and van der Laan and Rose (2011) for additional discussion.
Since Super Learning (and any other density estimation procedure) is tai-
lored for the estimation of Q, its bias-variance trade-off is not optimal for ψ . This
explains the need for the updating step in TMLE. In the updating step, we use the
initial estimate as a fixed offset, and fluctuate it by performing parametric regres-
sion with a so-called “clever covariate”, implied by the efficient influence curve,
that is constructed for optimal bias-variance trade-off with respect to ψ . For addi-
tional details, we refer the reader to van der Laan and Rubin (2006) and van der
Laan and Rose (2011).
Under regularity conditions, the resulting TMLE estimator ψˆ has the prop-
erty that
ψˆ −ψ0 ≈
1
n
n
∑
i=1
D∗(Oi) (12)
where ψ0 is the true parameter value, and D
∗ is the efficient influence curve. Sat-
isfying (12) results in many desirable properties. In particular, such an estimator
is asymptotically linear, consistent, and efficient. Asymptotic linearity refers to the
empirical mean representation, which allows us to make use of the Central Limit
Theorem and obtain valid inference. Consistency means our estimate is asymptoti-
cally unbiasedness, in the sense that ψˆ approaches the true value ψ0 as sample size
increases. Efficiency means that ψˆ has the minimum asymptotic variance (implied
by the efficient influence curve) among all asymptotically linear unbiased estima-
tors. Furthermore, a TMLE estimator is well-defined, in the sense that it does not
suffer frommultiple solutions. It is a substitution estimator, and thus respects global
constrains (for example, if ψ is a probability, the TMLE procedure will result in an
estimate between 0 and 1). The TMLE procedure is also double robust, and has
good performance for finite samples. For a additional details, we refer the reader to
van der Laan and Rubin (2006) and van der Laan and Rose (2011).
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4.2 Efficient Influence Curve
In order to proceed with the TMLE procedure, we need to determine the efficient
influence curve (also known as the canonical gradient) of ψ , which will allow us to
construct the clever covariate needed for the updating step of TMLE, as described
in Section 4.1.
As shown in Section 3.2, our VIM parameter of interest, ψ , only depends
on P through Q. As a result, we may derive the canonical gradient for ψ by first
finding any gradient D in a model in which g is known, and then projecting that
gradient into the tangent space of Q to obtain the canonical gradient.
Furthermore, from Section 3.2, ψ may be represented as an iterative con-
ditional expectation. As a result, van der Laan and Gruber (2011) show that the
efficient influence curve for ψ is: D∗ = D∗Y + D
∗
L′ + D
∗
W . We use the notation
D∗Z = Π(D|TZ) to represent the projection of D onto the tangent space TZ of QZ ,
for an arbitrary random variable Z. The D∗ components are given by:
D∗Y =
I(A = a,∆ = 1)
gA(a|W ) g∆(1|W,a,L′)
(
Y − Q¯a,1Y
)
D∗L′ =
I(A = a)
gA(a|W )
(
Q¯
a,1
Y − Q¯
a,1
L′
)
D∗W = Q¯
a,1
L′
−ψ(Q¯a,1W )


(13)
4.3 Interval-Censored TMLE of Variable Importance Measures
Following the general interval-censored TMLE development of Carone, Petersen,
and van der Laan (2012) and the TMLE of an intervention specific mean outcome
described in van der Laan and Gruber (2011), we estimate variable importance mea-
sures in the presence of interval-censored outcomes using the following IC-TMLE
algorithm. Note that, although the parametric fluctuation could take different forms,
the logistic regression model used below ensures that the fluctuations respect the
characteristics of the observed data. For further discussion, see Gruber and van der
Laan (2010).
We begin by obtaining an initial estimate Q¯
a,1
Y,n of the first conditional mean
outcome Q¯
a,1
Y = E[Y |W,A= a,L
′,∆= 1] by regressingY onto {W,A= a,L′,∆= 1}.
This initial estimate can be obtained using, for example, parametric logistic regres-
sion or data-adaptive Super Learning. Second, we fluctuate this initial estimate to
obtain an updated estimate Q¯
a,1,∗
Y,n . To do the update, we use the initial estimate as
a fixed offset, and perform a univariate regression of Y onto the clever covariate
I(A=a,∆=1)
gAg∆
.
Hosted by The Berkeley Electronic Press
Next, we obtain an initial estimate Q¯
a,1
L′,n
of the second conditional mean
outcome Q¯
a,1
L′
= E
[
Q¯
a,1
Y |W,A= a
]
by regressing the TMLE Q¯
a,1,∗
Y,n from the previous
step onto {W,A = a}. As before, this initial estimate is then fluctuated to obtain an
updated estimate Q¯
a,1,∗
L′,n
. The update is obtained by using the initial estimate as a
fixed offset in a univariate regression of the TMLE Q¯
a,1,∗
Y,n onto the clever covariate
I(A=a)
gA
.
Finally, we estimate Q¯
a,1
W = E
[
Q¯
a,1
L′
]
as the empirical mean of the TMLE
from the previous step: Q¯
a,1,∗
W,n =
1
n ∑
n
i=1 Q¯
a,1,∗
L′,n
(Wi). This same estimate also gives the
TMLE of ψ , sinceψ
(
Q¯a,1
)
= Q¯a,1W . Hence, the TMLE ofψ isψ
∗= 1
n ∑
n
i=1 Q¯
a,1,∗
L′,n
(Wi).
In Appendix D we provide a concrete description of how to implement the
IC-TMLE algorithm in practice.
5 Simulation Studies
In this section, we present simulations comparing our IC-TMLE procedure to sev-
eral alternative methods: a TMLE ignoring interval censoring by using forward im-
putation (F-TMLE), a TMLE ignoring interval censoring by using only complete
case data (CC-TMLE), a mean outcome within treatment groups using forward im-
putation (F-Mean), and a mean outcome within treatment groups using only com-
plete case data (CC-Mean).
In each of our simulated datasets, A ∼ Bern(0.5), and hence, mean out-
comes within treatment groups using only complete case data would be unbiased
if censoring was uninformative. Also, note that both alternative TMLE procedures
estimate well-defined effect measures for the data structure they analyze (forward
imputed data, or complete case data), but nonetheless fail to take interval-censoring
into account.
5.1 Simulated Data Structure
Our simulated data structure is as follows. Two covariates (Lt,1,Lt,2) collected over
time, a binary treatment A assigned at baseline, and a binary outcome Yt collected
over time. The outcome at baseline is zero for all observations: Y0 = 0. The co-
variates and outcome are collected at baseline t = 0, and at each of two subsequent
follow-up times t = 1,2. There is no censoring at baseline, so ∆0 = 1, but each
subsequent follow-up time is subject to censoring. The outcome of interest is the
outcome value at the final follow-up time τ = 2.
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5.2 Motivating Example: Inadequacy of Parametric Models
To motivate our IC-TMLE approach, we begin by presenting a simulation demon-
strating the failure of common logistic modeling approaches in the presence of in-
terval censored data. Logistic regression is an example of a parametric statistical
model, and hence makes the assumption that the data generating probability dis-
tribution is known up to a finite number of parameters. However, the underlying
data generating distribution is generally always unknown in any experimental or
observational study. Additionally, estimated odds ratios obtained via logistic re-
gression are conditional on the remaining covariates in the model being held fixed.
As a result, unless the logistic regression model is forced to not include interactions
(which is not justifiable), the resulting odds ratios are functions of these remaining
covariates, and hence are not well-defined effect measures. Furthermore, logis-
tic modeling approaches commonly used by practitioners often ignore the interval
censored structure of the data. Instead, ad hoc strategies such as complete case
analysis or forward imputation are typically employed in an attempt to mask the
interval censoring.
Our simulated data is generated as follows:
W1 ∼ N(0,1)
W2 ∼ U(−0.5,0.5)
A ∼ Bern(0.5)
Y0 = 0
∆1 ∼ Bern
(
expit(2−0.2W1−0.2W2+0.4W1A+0.4W2A)
)
L1 = W1+N(0.2,1)
L2 = W2+U(−1,0.5)
Y1 = max
(
Y0, Bern
(
expit(−2−W1−W2)
))
∆2 = max
(
Bern(0.3), Bern
(
expit(−2+2.5L1−5.5AL1)
))
Y2 = max
(
Y1, Bern
(
expit(3L1)
))


(14)
In the simulated data structure (14), the Yt process is a time-to-event out-
come since it begins at zero and and only jumps (at most) once to one. In the case
of Y1, this can be seen by observing that Y0 = 0, and the Bernoulli term is either 0
or 1. For Y2, the Bernoulli term is again either 0 or 1, and by taking the maximum
with Y1, we ensure that if Y1 already jumped to one, Y2 equals one.
Observe that A only affects the monitoring variables ∆1 and ∆2. As a result,
in truth, A has no effect on the outcome Y2, since Y2 is not a function of either ∆1
or ∆2. Hence, a successful logistic regression would estimate the coefficient of A to
be zero.
We generated a sample of size 1,000 from (14), and fitted two types of
logistic regression models to estimate the effect of A on Y2. In the first, we employ
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forward imputation to fill in the value of Y2 if ∆2 = 0, and regress Y2 onto A, W1,
W2. In the second, we use complete case analysis, and regress Y2 onto A, W1, W2,
but only among the observations with ∆2 = 1.
In the forward imputation approach, we obtain a coefficient estimate for A of
−0.18, with a p-value of< 0.001, and a 95% confidence interval of (−0.24,−0.12).
In the complete case analysis approach, we obtain a coefficient estimate for A of
−0.18, with a p-value of< 0.001, and a 95% confidence interval of (−0.26,−0.09).
Hence, both logistic regression approaches claim that A has a highly significant
effect on Y2, when in reality no such effect exists.
5.3 Simulation 1: No Effect of A on Y
In this simulation, we generated data from (14), as in Section 5.2. As described in
the previous section, variable A has no effect on Y . The true values of ψ1 and ψ0
are both 0.64, and the true risk difference is ψ = ψ1−ψ0 = 0. We performed 1000
simulations on each of sample sizes n = 200, 500, 1000. Results are presented in
Table 1.
The IC-TMLE method shows strong performance. It has the lowest bias
and MSE for ψ1 and ψ0 across all sample sizes. As sample size increases, bias and
MSE decrease for all parameters. Coverage rate is high across all sample sizes, and
improves with sample size.
Each of the other methods exhibit undesirable behavior. Bias for all param-
eters tends to stay constant with increasing sample size, and coverage rates decrease
as sample size increases. Since the true value of ψ is zero, the low coverage rates
mean that the competing methods tend to claim a significant effect, when in fact no
such effect exists. At sample size 1000, each competing method has coverage rate
under 5%, meaning that each competing method claims a false significant effect
over 95% of the time.
Although F-MEAN has low bias for ψ , this is only due to the lucky fact
that the large biases in ψ1 and ψ0 cancel out in the risk difference. Alternative
parameters, e.g., relative risk, would not have bias cancellation. Even though F-
MEAN’s bias for ψ is low, coverage for ψ is poor. At sample size 200, F-MEAN
has a coverage rate of roughly 31%, and by sample size 1000, the coverage rate has
dropped to 0%.
5.4 Simulation 2: A Affects Y
In this simulation, we generated data according to the laws below. Here, the variable
A has a positive effect on Y . The true value of ψ1 is 0.80, the true value of ψ0 is
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Table 1: Simulation 1 results. The best performing method in each row is in bold.
IC-TMLE F-TMLE CC-TMLE F-MEAN CC-Mean
n = 200
BIAS
ψ -0.0670 -0.1661 -0.1475 -0.0001 -0.2216
ψ1 -0.0402 -0.3337 -0.0705 -0.3338 -0.1090
ψ0 0.0267 -0.1676 0.0770 -0.3337 0.1127
MSE
ψ 0.0160 0.0323 0.0321 0.0321 0.0588
ψ1 0.0070 0.1136 0.0105 0.1136 0.0176
ψ0 0.0062 0.0307 0.0109 0.0308 0.0164
COVER
ψ 0.856 0.305 0.647 0.309 0.364
n = 500
BIAS
ψ -0.0164 -0.1673 -0.1553 -0.0001 -0.2260
ψ1 -0.0114 -0.3344 -0.0729 -0.3345 -0.1106
ψ0 0.0051 -0.1671 0.0823 -0.3344 0.1153
MSE
ψ 0.0039 0.0300 0.0279 0.0299 0.0546
ψ1 0.0018 0.1127 0.0074 0.1128 0.0143
ψ0 0.0018 0.0289 0.0086 0.0290 0.0148
COVER
ψ 0.959 0.029 0.265 0.029 0.038
n = 1000
BIAS
ψ 0.0055 -0.1688 -0.1549 -0.0001 -0.2272
ψ1 0.0001 -0.3354 -0.0727 -0.3354 -0.1117
ψ0 -0.0046 -0.1666 0.0822 -0.3353 0.1157
MSE
ψ 0.0018 0.0295 0.0258 0.0295 0.0533
ψ1 0.0008 0.1129 0.0063 0.1129 0.0134
ψ0 0.0008 0.0282 0.0076 0.0282 0.0140
COVER
ψ 0.979 0.000 0.046 0.000 0.000
0.72, and the true risk difference is ψ = ψ1−ψ0 = 0.08.
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W1 ∼ N(0,1)
W2 ∼ U(−0.5,0.5)
A ∼ Bern(0.5)
Y0 = 0
∆1 ∼ Bern
(
expit(−3W1A+8W2A+2W1(1−A)−2(1−A)W2)
)
L1 = W1+0.1A+N(0.2,1)
L2 = W2+0.1A+U(−1,0.5)
Y1 = max
(
Y0, Bern
(
expit(W1−W2+0.05A)
))
∆2 = max
(
Bern(0.3), Bern
(
expit(−2+10L1A−10L2A−15L1(1−A)+15L2(1−A)−0.2A)
))
Y2 = max
(
Y1, Bern
(
expit(−2L1+2L2+0.1A)
))


(15)
As in the previous simulation, we performed 1000 simulations from (15) on
each of sample sizes n = 200, 500, 1000. Results appear in Table 2.
IC-TMLE has the lowest bias and highest coverage across all sample sizes.
Bias and MSE decrease as sample increases, coverage and correctly signed confi-
dence interval rates increase with sample size, and incorrectly signed confidence
interval rate decreases as sample size increases.
Other methods show relatively constant bias with increasing sample size,
lower coverage rate and fewer correctly signed confidence intervals with increas-
ing sample size, and more incorrectly signed confidence intervals as sample size
increases. A bias comparison for ψ1 is particularly informative: across all sample
sizes, each of the competing methods retains high bias, while IC-TMLE starts out
with the lowest bias and also steadily reduces bias at each increase in sample size.
The competing methods are also particularly poor in terms of coverage: coverage
rates are low, incorrect significant effects are often claimed, and correct significant
effects are rarely found.
6 Data Analysis
6.1 InC3 Data
The “International Collaboration of Incident HIV and HCV in Injecting Cohorts”
(InC3) is a merged international multi-cohort project of pooled observational lon-
gitudinal data, both biological and behavioral, from 9 prospective cohorts of injec-
tion drug users (IDU). Hepatitis C virus (HCV) is a particularly common infection
among injection drug users, and spontaneous viral clearance of HCV is often ob-
served. However, the determinants of spontaneous viral clearance of HCV infection
among injection drug users have not been extensively studied. Understanding the
http://biostats.bepress.com/ucbbiostat/paper307
Table 2: Simulation 2 results. The rows ψ , ✁0 and ψ , ✁0 indicate the fraction of 95%
confidence intervals for ψ claiming a significant result with the correct (positive)
sign and incorrect (negative) sign, respectively. The best performing method in each
row is in bold.
IC-TMLE F-TMLE CC-TMLE F-MEAN CC-Mean
n = 200
BIAS
ψ -0.0309 -0.1561 -0.0883 -0.0795 -0.0836
ψ1 -0.0190 -0.3824 -0.0624 -0.3822 -0.0605
ψ0 0.0118 -0.2263 0.0259 -0.3028 0.0231
MSE
ψ 0.0105 0.0296 0.0174 0.0298 0.0164
ψ1 0.0039 0.1488 0.0082 0.1487 0.0079
ψ0 0.0057 0.0537 0.0056 0.0536 0.0054
COVER
ψ 0.924 0.387 0.810 0.396 0.836
ψ , ✁0 0.095 0.001 0.021 0.002 0.023
 ψ , ✁0 0.012 0.229 0.043 0.217 0.031
n = 500
BIAS
ψ -0.0176 -0.1582 -0.0914 -0.0795 -0.0879
ψ1 -0.0128 -0.3838 -0.0651 -0.3837 -0.0639
ψ0 0.0048 -0.2256 0.0263 -0.3042 0.0239
MSE
ψ 0.0039 0.0270 0.0119 0.0271 0.0113
ψ1 0.0014 0.1483 0.0059 0.1482 0.0057
ψ0 0.0021 0.0518 0.0027 0.0518 0.0025
COVER
ψ 0.943 0.047 0.647 0.064 0.687
ψ , ✁0 0.155 0.000 0.017 0.000 0.017
 ψ , ✁0 0.002 0.439 0.046 0.430 0.044
n = 1000
BIAS
ψ -0.0118 -0.1591 -0.0935 -0.0795 -0.0899
ψ1 -0.0082 -0.3841 -0.0647 -0.3840 -0.0636
ψ0 0.0036 -0.2249 0.0288 -0.3045 0.0263
MSE
ψ 0.0017 0.0262 0.0105 0.0262 0.0098
ψ1 0.0006 0.1480 0.0050 0.1479 0.0049
ψ0 0.0010 0.0511 0.0018 0.0511 0.0017
COVER
ψ 0.961 0.000 0.396 0.000 0.431
ψ , ✁0 0.303 0.000 0.008 0.000 0.013
 ψ , ✁0 0.000 0.723 0.047 0.718 0.039
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factors that play a role in driving HCV clearance is of significant interest, as doing
so would aid in the identification of risk factors for chronic infection, as well as
suggest possible directions for pharmaceutical development.
Merge 1 data from the InC3 project consists of baseline and longitudinal
data collected on 522 HCV infected injection drug users across the 9 study cohorts.
Data about IDU from different cohorts are similar in several ways. For example,
each cohort aimed to schedule regularly spaced visits for follow-up (although a
scheduled visit is not the same as an actual visit!), and collected similar behavioral
and biological measurements for each IDU. However, data about IDU from differ-
ent cohorts also differs in several ways. For example, each cohort used different
follow-up intervals, and may not have collected all desired behavioral or biological
measurements. As a result, the data is interval censored and consists of missing
observations. Some IDU also received drug therapy to treat their HCV infection,
resulting in right-censoring of the spontaneous clearance outcome. We refer to Gre-
bely et al. (2012b) and the InC3 website (2013) for additional details about the InC3
cohort.
6.2 Previous Work
Grebely et al. (2012a) used logistic regression to model the binary outcome of HCV
clearance within 2 years of estimated incident infection as a function of variables of
interest to analyze factors associated with spontaneous clearance. As demonstrated
in Section 5.2, this type of forward imputation logistic regression modeling does not
account for interval censoring, and often results in incorrect estimates and inference.
6.3 Analysis
We apply IC-TMLE to estimate variable importance measures for the effects of age,
ethnicity, gender, infecting genotype, and IL28B gene on the interval-censored out-
come of spontaneous HCV clearance among injection drug users in the InC3 data.
Following Grebely et al. (2012a), we defined clearance as two consecutive HCV
RNA negative tests, and analyzed clearance within 2 years of incident infection. If
clearance was observed for an IDU, all subsequent clearance outcomes were also
set to clearance being true.
Since the focus of this paper is the interval censored nature of the clear-
ance outcome, we handled interval-censoring of the initial infection date and right-
censoring of the outcome as follows. The first time infection was observed was
used as the incident infection time t = 0. We used Inverse Probability of Censor-
ing Weighting (IPCW) prior to applying the IC-TMLE procedure to account for
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the right-censoring of spontaneous clearance for IDU who received drug therapy
to treat their HCV infection. Using IPCW to weight the original observed data
structure before applying a TMLE is sub-optimal, but still retains many desirable
efficiency and robustness properties. For additional details, we refer to van der
Laan and Rose (2011). The number of IDU not receiving HCV drug therapy is
n1+n0 = 429.
Given our assumed Structural Causal Model, variables included in W are
different depending for each variable A we analyze. In particular, variables included
in W cannot be affected by A. To account for this, we grouped available baseline
variables into several categories (personal, date, location, gene, base-behavior, and
age) describing their general type. Personal baseline variables included unchanging
characteristics of study participants, such as gender, origin, and ethnicity. Date
baseline variables included all year or date variables, such as birth date and cohort
entry date. Location baseline variables included location-specific information, such
as site and center. Gene baseline variables included values of all measured genes.
Base-behavior variables included baseline information about injection and prison
prior to HCV infection. Age baseline variables included the ages of the IDU at
various life events, such as age at cohort entrance. Note that all of these variables
are required to have occurred prior to HCV infection. If such information was not
available (e.g., the participant was already infected with HCV upon entrance to a
cohort), the variables were treated as missing.
When A represented IL28B or age, W included personal, date, location,
gene, and age baseline variables. When A represented ethnicity or gender, W in-
cluded personal, date, location, and gene baseline variables. When A represented in-
fecting genotype,W included personal, date, location, gene, age, and base-behavior
variables.
We analyzed factors A which had at least 15 IDU with A = 1. We did not
analyze, for example, Asian ethnicity, since the number of Asian IDU was below
15. For this reason, the numbers within each variable analyzed do not necessarily
sum to the total number of IDU within the dataset.
L′ consisted of all baseline variables not included inW (and therefore is also
different depending on A), as well as the time-dependent variables collected at the
last monitoring time prior to 1 year after incident infection date. ∆ was an indicator
of being monitored between 1 year and 2 years after incident infection date. Y was
an indicator of whether clearance was observed between 1 year and 2 years after
incident infection date. Note that, due to our definition of clearance, if clearance
was observed prior to 1 year, and ∆ = 1, then Y = 1, as well. On the other hand,
if clearance was observed prior to 1 year, but ∆ = 0, recall from Section 3.1.3 that
we still effectively know that clearance has occurred, and our estimates will not be
changed.
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We selected the monitoring interval of between 1 and 2 years from incident
infection date for several reasons. First, we are able to analyze all clearance prior
to 2 years, as in Grebely et al. (2012a). Second, clearance of acute HCV infection
typically occurs within 1 year of infection, as discussed in Page et al. (2009) and
Grebely et al. (2012c). Third, using smaller intervals resulted in many fewer IDU
being observed within the interval, resulting in poorer estimates. Together, this ra-
tionale was an attempt to balance the trade-off between, on the one hand, obtaining
precise estimates through having a large enough number of IDU with ∆= 1, and, on
the other hand, obtaining results with strong interpretation by using a small window
to examine the time-to-event outcome of clearance at a specific time.
6.4 Results
The results of our analysis are presented in Table 3. Female gender, IL28B CC, and
several middle age ranges showed a significantly positive effect on HCV clearance.
Unknown gender, all other IL28B analyzed, unknown and indigenous ethnicity,
infecting genotype 2 and 3, and several younger and older age ranges showed a
significantly negative effect on HCV clearance.
It is important to note that estimates may be poor and confidence intervals
may be overly optimistic (i.e., too small) when min(n0,n1) is small, where n1 and
n0 are the number of IDU with A = 1 and A = 0, respectively. For example, when
min(n0,n1) is small, our estimate of variance may not be able to detect whether the
true variance of ψ is large. This is due to the fact that, in our case, the term gA in
the denominator of two of the influence curve components in (13) is the conditional
probability that A = a given covariates W . We might expect gA to be small, and
hence, the variance to be large. However, for factors with small min(n0,n1), we
may not observe participants where gA is small, resulting in variance estimates and
confidence intervals that are artificially small.
6.5 Considerations for Future Analyses
While this paper’s focus was on the interval censored nature of the HCV clearance
outcome in the InC3 data, several other considerations would be fruitful for further
analysis.
Future analysis should note that if the factor of interest A has a very small
number of people (e.g., 21 participants with infecting genotype 2 in the Merge 1
InC3 dataset), the VIM of A may be excessively determined by the specific indi-
viduals within that small group. As a result, factors where min(n0,n1) was very
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Table 3: InC3 analysis results. Check marks in the “95% Sig” column indicate that
the analyzed variable had a significant effect on clearance, at the 95% level, and n1
and n0 are the number of IDU with A = 1 and A = 0, respectively.
95% Sig ψˆ 95% CI min(n0,n1)
Age
Age < 20 X -0.235 (-0.291, -0.178) 25
Age < 25 X -0.154 (-0.232, -0.075) 179
Age < 30 0.011 (-0.071, 0.094) 120
Age < 35 X 0.147 (0.082, 0.213) 63
Age < 40 X 0.218 (0.160, 0.277) 34
Age 20-40 X 0.184 (0.129, 0.239) 69
Age 20-35 X 0.088 (0.024, 0.152) 98
Age 25-35 -0.040 (-0.152, 0.072) 187
Age 25-40 X 0.093 (0.012, 0.174) 213
Gender
Male -0.081 (-0.196, 0.035) 260
Female X 0.125 (0.016, 0.233) 154
Unknown X -0.262 (-0.316, -0.208) 15
Genotype
1 -0.029 (-0.136, 0.077) 157
2 X -0.275 (-0.360, -0.190) 21
3 X -0.125 (-0.214, -0.035) 97
Not Done 0.036 (-0.072, 0.145) 127
IL28B
CC X 0.194 (0.098, 0.291) 190
CT X -0.165 (-0.260, -0.070) 146
TT X -0.181 (-0.288, -0.075) 46
Missing X -0.183 (-0.270, -0.097) 38
Ethnicity
White 0.037 (-0.062, 0.135) 104
Indigenous X -0.251 (-0.340, -0.163) 31
Other 0.168 (-0.159, 0.495) 16
Unknown X -0.254 (-0.306, -0.202) 29
small should be investigated further for a dataset with larger min(n0,n1) to estab-
lish whether or not the effect remains. Furthermore, improved variance estimation
methods for sparse data of this nature are needed.
Additional choices of the ∆ monitoring interval should also be studied. We
attempted to balance the trade-off between precise and interpretable estimates, but
additional analysis should be done to analyze the sensitivity of conclusions pre-
sented here to alternative choices of ∆.
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7 Discussion
While most experimental and observational data, particularly in genetics and epi-
demiology, is interval-censored, practitioners consistently fail to account for interval-
censored outcomes in their analyses of variable importance measures. In this paper,
we demonstrated that ignoring interval-censored outcomes leads to biased estimates
and incorrect inference. We presented a TMLE algorithm tailored for estimating
VIM in the presence of interval-censored outcomes, IC-TMLE. We discussed the
desirable statistical properties of IC-TMLE, showed its superior performance com-
pared to other methods through a series of simulation studies, and used it to estimate
VIM of spontaneous HCV clearance using the InC3 data.
The IC-TMLE procedure provides VIM estimates that can be used to deter-
mine the effects of a large collection of variables on an outcome subject to interval-
censoring. The ubiquity of interval-censored outcomes and the importance of ob-
taining valid variable importance measures indicate the wide-ranging applicability
of our novel IC-TMLE approach to estimating VIM in the presence of interval-
censored outcomes.
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Appendices
A Identifiability of Static Intervention Parameter
In an ideal (impossible) experiment, we would observe the static intervention (3) on
all participants for both a values, and the causal effect of A on Y could be estimated
by using the counterfactual outcomes to directly compute the empirical average
ψˆFstatic =
1
n ∑
n
i=1(Y
1,1
i −Y
0,1
i ). Of course, in reality, we can never conduct the ideal
experiment described by (3) (which explains why the data is called counterfactual).
Instead, for (2) to be identifiable from the observed data, we need the following
causal assumptions:
(C1) Y a,1 = Y A,1|A = a
Consistency 1: Intervening on the NPSCM to set treatment to A = a yields
the observed data if the actual observed treatment is A = a.
(C2) Y A,1 = Y A,∆|∆ = 1
Consistency 2: Intervening on the NPSCM to set monitoring to ∆ = 1 yields
the observed data if the actual observed monitoring is ∆ = 1.
(R1) Y a,1 ⊥⊥ A |W
Randomization 1: No unmeasured confounders associated with both treat-
ment A and counterfactual outcome Y a,1.
(R2) Y a,1 ⊥⊥ ∆ |W,A = a,L′
Randomization 2: No unmeasured confounders associated with both moni-
toring ∆ and counterfactual outcome Y a,1.
(P1) P(A = a|W )> 0
Positivity 1: Conditional probability of treatment, for both a = 1 and a = 0,
is positive for all covariate possibilities W .
(P2) P(∆ = 1|W,A = a,L′)> 0
Positivity 2: Conditional probability of monitoring at time τ is positive for all
covariate possibilities W, A, L′.
Under the above assumptions, we may express the components of ψFstatic as follows.
Note that we use the shorthand notation EL′ to indicate the expectation with respect
to the conditional distribution of L′ | W,A = a. The abbreviation TR stands for the
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Tower Rule.
E[Y a,1]
(TR)
= EW
[
E
[
Y a,1|W
]]
(R1), (P1)
= EW
[
E
[
Y a,1|W,A = a
]]
(C1)
= EW
[
E
[
Y A,1|W,A = a
]]
(TR)
= EW
[
EL′
[
E
[
Y A,1|W,A = a,L′
]]]
(R2), (P2)
= EW
[
EL′
[
E
[
Y A,1|W,A = a,L′,∆ = 1
]]]
(C2)
= EW
[
EL′
[
E
[
Y A,∆|W,A = a,L′,∆ = 1
]]]
(16)
Equation (16) is a function of the distribution of the observed data, allowing us to
identify (2) from the observed data.
B Identifiability of Stochastic Intervention Parame-
ter
Ideally, we would observe the stochastic intervention (7) on all participants for
both a values, and the causal effect of A on Y could be estimated by using the
counterfactual outcomes to directly compute the empirical average ψˆFstochastic =
1
n ∑
n
i=1(Y
#,1,δ
i −Y
#,0,δ
i ). Since the ideal experiment described by (7) is not possi-
ble, for (6) to be identifiable from the observed data, we need the following causal
assumptions:
(C1) Y #,a,δ = Y #,A,δ |A = a
(C2) Y #,A,δ = Y #,A,∆
#
|∆# = δ
(R1) Y #,a,δ ⊥⊥ A |W
(R2) Y #,a,δ ⊥⊥ ∆# |W,A = a,L
′#
(P1) P(A = a|W )> 0
(P2) P(∆# = δ |W,A = a,L
′#)> 0
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Under the above assumptions, we may express the components of ψFstochastic as fol-
lows:
E[Y #,a,δ ]
(TR)
= EW
[
E
[
Y #,a,δ |W
]]
(R1), (P1)
= EW
[
E
[
Y #,a,δ |W,A = a
]]
(C1)
= EW
[
E
[
Y #,δ |W,A = a
]]
(TR)
= EW
[
E
L
′#
[
E
[
Y #,δ |W,A = a,L
′#
]]]
(R2), (P2)
= EW
[
E
L
′#
[
E
[
Y #,δ |W,A = a,L
′#
,∆# = δ
]]]
(C2)
= EW
[
E
L
′#
[
E
[
Y #|W,A = a,L
′#
,∆# = δ
]]]
(17)
As before, the last equation above is a function of the distribution of the observed
data, allowing us to identify (6) from the observed data.
C Proof of Equivalence of Intervention Formulations
Under the stochastic intervention, from equation (17), we have that
E[Y #,a,δ ] = EW
[
E
L
′#
[
E
[
Y #
∣∣∣∣W,A = a,L′#,∆# = δ
]]]
= EW
[
E
L
′#
[
E
[
Y #(τ −1)+
(
1−Y #(τ −1)
)
Y ∗(τ)
∣∣∣∣W,A = a,L′#,∆# = δ
]]]
= EW
[
E
L
′#
[
Y #(τ −1)+(1−Y #(τ −1))E
[
Y ∗(τ)
∣∣∣∣W,A = a,L′#,∆# = δ
]]]
(18)
Now, since Y #(τ −1) ∈ L
′# and Y #(τ −1) is binary, we can simplify
E
[
Y ∗(τ)
∣∣∣∣W,A = a,L′#,∆# = δ
]
(19)
by considering the value of Y #(τ −1) and the definition of δ :
Hosted by The Berkeley Electronic Press
(19) = E
[
Y ∗(τ)
∣∣∣∣W,A = a,L′#,∆# = (1−Y #(τ −1))+Y #(τ −1)∆#(τ −1)
]
= E
[
Y ∗(τ)
∣∣∣∣W,A = a,L′#,∆# = 1
]
Y #(τ −1)+E
[
Y ∗(τ)
∣∣∣∣W,A = a,L′#,∆# = 1
]
(1−Y #(τ −1))
= E
[
Y ∗(τ)
∣∣∣∣W,A = a,L′#,∆# = 1
]
(20)
The above calculations hold because, no matter the value of Y #(τ − 1), the
stochastic intervention results in ∆# = 1. This can be seen by noting that if Y #(τ −
1) = 1, then ∆#(τ−1) = 1, resulting in ∆#(τ) = 1. On the other hand, ifY #(τ−1) =
0, the stochastic intervention also tells us to set ∆#(τ) = 1. Now, using the equality
of (19) and (20), we can simplify equation (18) as:
(18) = EW
[
EL′#
[
Y #(τ −1)+(1−Y #(τ −1))E
[
Y ∗(τ)
∣∣∣∣W,A = a,L′#,∆# = 1
]]]
(21)
Under the static intervention, from equation (16), we have:
E[Y a,1] = EW
[
EL′
[
E
[
Y ∗(τ)|W,A = a,L′,∆ = 1
]]]
= EW
[
EL′
[
E
[
Y ∗(τ)|W,A = a,L′,∆ = 1,Y #(τ −1) = 1
]
Y #(τ −1)
+ E
[
Y ∗(τ)|W,A = a,L′,∆ = 1,Y #(τ −1) = 0
]
(1−Y #(τ −1))
]]
= EW
[
EL′
[
Y #(τ −1)+(1−Y #(τ −1))E
[
Y ∗(τ)|W,A = a,L′,∆ = 1
]]]
(22)
To see the equivalence of (21) and (22), observe that the only difference lies
in the use of L′ versus L′#. However, L′ and L′# contain equivalent information:
L′# was constructed from L′, which shows that any information contained in L′#
is also contained in L′, and on the other hand, the data redefinition equations can
easily be used to derive L′ from L′#. Finally, since both versions of the data con-
tain identical information, the causal assumptions needed for identifiability are also
interchangeable.
D Practical IC-TMLE Algorithm Implementation
To clarify the description of IC-TMLE provided in the main article, we provide here
a more concrete and detailed description of the practical steps needed to implement
the algorithm.
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IC-TMLE algorithm
0. Obtain initial estimators gA,n(a|w) of gA(a|w) and g∆,n(1|w,a, l
′) of g∆(1|w,a, l
′)
using Super Learning.
1. Obtain initial estimator Q¯
a,1
Y,n of Q¯
a,1
Y by using Super Learning to perform lo-
gistic regression of Y onto W and L′ among the observations with A = a and
∆ = 1.
2. Fit a parametric logistic regression, among observations with A = a and ∆ =
1, of Y onto clever covariate
I(A = a)I(∆ = 1)
gA,n(a)g∆,n(1)
, offset by the fitted values
from Q¯
a,1
Y,n (making sure to set these fitted values equal to 1 for any observa-
tions with Yt = 1 for some Yt ∈ L
′). Obtain Q¯
a,1,∗
Y,n .
3. Obtain initial estimator Q¯
a,1
L′,n
of Q¯
a,1
L′
by using Super Learning to perform
logistic regression of Q¯
a,1,∗
Y,n ontoW , among the observations with A= a. Note
that we calculate the clever covariate of Q¯
a,1,∗
Y,n as
I(A = a) [I(∆ = 1) = 1]
gA,n(a)g∆,n(1)
, i.e.,
we calculate the clever covariate setting A = a and ∆ = 1 for all observations
with A = a. Similarly, we calculate the offset of Q¯a,1,∗Y,n using predictions from
Q¯
a,1
Y,n for all observations with A = a. Furthermore, if a built-in method to
obtain predictions from a glm object with offset is not available (e.g., R),
Q¯
a,1,∗
Y,n must be calculated manually.
4. Fit a parametric logistic regression, among observations with A = a, of Q¯a,1,∗Y,n
(calculated as described in the previous step) onto clever covariate
I(A = a)
gA,n(a)
,
offset by the fitted values from Q¯
a,1
L′,n
(note that we do not need to set any of
these fitted values equal to 1, since Y0 = 0 for all observations). Obtain Q¯
a,1,∗
L′,n
.
5. Estimate Q¯
a,1
W with the empirical mean Q¯
a,1
W,n =
1
n
n
∑
i=1
Q¯
a,1,∗
L′,n
(Wi). This is also
the TMLE Q¯
a,1,∗
W,n , as well as the TMLE of ψ(Q¯
a,1,∗
n ), since Q¯
a,1,∗
W,n =ψ(Q¯
a,1,∗
n ).
Note that we calculate Q¯
a,1,∗
L′,n
among all observations, and the procedure is
analogous to the procedure for calculating Q¯
a,1,∗
Y,n described above. To be
explicit, we obtain the offset using the predictions from Q¯
a,1
L′,n
for all observa-
tions, set the clever covariate to the case that A = a for all observations, and
calculate the predictions from a glm object with offset (manually, if needed).
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